Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular Structure of Gardenia Blue Pigments by Reaction of Genipin with Benzylamine and Amino Acids.
Tsutsumiuchi K, Toyoshima T, Hasegawa F, Terasawa R, Honda W, Sakakibara M, Ishida Y, Ikai Y, Ishibashi R, Furuya K, Morimoto T, Ishizuki K, Nishizaki Y, Masumoto N, Sugimoto N, Sato K, Oka H. Tsutsumiuchi K, et al. Among authors: terasawa r. J Agric Food Chem. 2021 Apr 7;69(13):3904-3911. doi: 10.1021/acs.jafc.0c07948. Epub 2021 Mar 24. J Agric Food Chem. 2021. PMID: 33761247
Clinical implications of elevated serum interleukin-6 in IgG4-related disease.
Tsukuda S, Ikeura T, Ito T, Nakamaru K, Masuda M, Hori Y, Ikemune M, Yanagawa M, Tanaka T, Tomiyama T, Yamaguchi T, Ando Y, Uchida K, Fukui T, Nishio A, Terasawa R, Tanigawa N, Okazaki K. Tsukuda S, et al. Among authors: terasawa r. PLoS One. 2020 Jan 17;15(1):e0227479. doi: 10.1371/journal.pone.0227479. eCollection 2020. PLoS One. 2020. PMID: 31951598 Free PMC article.
De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer.
Tanaka S, Matsunami N, Morishima H, Oda N, Takashima T, Noda S, Kashiwagi S, Tauchi Y, Asano Y, Kimura K, Fujioka H, Terasawa R, Kawaguchi K, Ikari A, Morimoto T, Michishita S, Kobayashi T, Sakane J, Nitta T, Sato N, Hokimoto N, Nishida Y, Iwamoto M. Tanaka S, et al. Among authors: terasawa r. Cancer Chemother Pharmacol. 2019 Jun;83(6):1099-1104. doi: 10.1007/s00280-019-03836-z. Epub 2019 Apr 8. Cancer Chemother Pharmacol. 2019. PMID: 30963212 Clinical Trial.
A phase II, multicenter, single-arm trial of eribulin as first- or second-line chemotherapy for HER2-negative advanced or metastatic breast cancer: evaluation of efficacy, safety, and patient-reported outcomes.
Kimura K, Iwamoto M, Tanaka S, Yamamoto D, Yoshidome K, Ogura H, Terasawa R, Matsunami N, Takahashi Y, Nitta T, Morimoto T, Fujioka H, Kawaguchi K, Uchiyama K. Kimura K, et al. Among authors: terasawa r. Cancer Chemother Pharmacol. 2018 May;81(5):923-933. doi: 10.1007/s00280-018-3567-y. Epub 2018 Mar 28. Cancer Chemother Pharmacol. 2018. PMID: 29594360 Clinical Trial.
27 results